<DOC>
	<DOCNO>NCT00909285</DOCNO>
	<brief_summary>Current diagnosis Alzheimer disease make clinical , neuropsychological , neuroimaging assessment . Routine structural neuroimaging evaluation base nonspecific feature , atrophy , late feature progression disease . Therefore , develop new approach early specific recognition Alzheimer disease prodromal stag crucial importance . In present study investigator would like examine combine treatment TMS cognitive training ( CoTra ) several week produce sustain improvement cognitive behavioral symptomatology Alzheimer 's disease ( AD ) patient . A number vivo neuroimaging technique , use reliably noninvasively assess aspect neuroanatomy , chemistry , physiology , pathology , hold promise .</brief_summary>
	<brief_title>Effects Transcranial Magnetic Stimulation ( TMS ) Cognitive Training Alzheimer Patients</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Male female age 5585 year Patients diagnose early moderate stage Alzheimer 's disease , accord DSMIV criterion . MMSE score 15 26 Global Dementia rating 1 2 Physically acceptable study confirm medical history exam , clinical laboratory result EKG Spouse , family member professional caregiver agree capable take care responsibility participation patient study ( transportation patient investigator 's clinic , answer question regard patient 's condition assume responsibility medication ) Written informed consent patient legally responsible caregiver . Able undergo MRI scanning session ( e.g. , prior onset study , upon attainment primary endpoint end study ) . Commitment participation sixto eighteen week trial regimen consist approximately1 hour TMS stimulation cognitive training daily treatment five day week six eighteen week ( two treatment day case Third TMS stimulation cognitive training Treatment protocol necessary ) . Severe agitation ; Mental retardation ; Unstable medical condition ; Use benzodiazepines hypnotic study precede two week ; Pharmacological immunosuppression ; Participation clinical trial investigational agent within two week prior study enrollment ; Alcoholism ; History Epileptic Seizures Epilepsy ; Contraindication perform MRI scanning ; Clinically significant abnormal laboratory finding approve Project Director ;</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Alzheimer</keyword>
	<keyword>TMS</keyword>
	<keyword>cognitive training</keyword>
</DOC>